Base de données FAIR Heart failure Nuclear envelope Actionability Regeneration Biological sciences RNA interference Angiotensin-converting enzyme inhibitors Clinical trial Muscle biopsy LMNA gene Acetyltransferase Muscular dystrophy MD Angiotensin-converting enzyme inhibitor Myogenesis Becker muscular dystrophy Diagnosis Lamin A/C nuclei COL6A1 Therapy Cardiomyopathy Next generation sequencing LGMD Hypermobile EDS LMNA-related congenital muscular dystrophy Congenital muscular dystrophy Alternative splicing Connective tissue COL1A1 C elegans Butyrylcholinesterase LMNA Errance diagnostique Lamin A/C COVID-19 CRISPR GNE Heart Treatment Cardiac conduction system Dystrophine Titin Allele‐specific silencing therapy Duchenne muscular dystrophy Laminopathy BiP Ehlers‐Danlos Syndrome Dilated cardiomyopathy Lamins C2C12 Laminopathies POPDC1 Mouse Adult SMA CMTX COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders Maladies rares Biomarker Myopathy Exome Myologie Muscle Rare diseases Neuromuscular diseases Dynamin 2 Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS BVES Myopathies Autophagosome maturation Actionable gene Calcium handling Laminopathie A-type lamin Emerin AAV VECTOR Gene therapy Patient registry Rare neuromuscular diseases CSF protein Mutations Cancer Maladies rares et orphelines Myotubes Joint laxity Lamin A/C LMNA gene Skeletal muscle Allele-specific silencing therapy Dystrophie musculaire Allele-specific silencing Muscle MRI A-type lamins Emery-Dreifuss muscular dystrophy Centronuclear myopathy INPP5K Treatment delay IPSC Muscular dystrophy Cancer biomarkers AAV Cardiology